Lai C.-C.Tan C.-K.Liao C.-H.Chou C.-H.Hsu H.-L.YU-TSUNG HUANGPAN-CHYR YANGKWEN-TAY LUHPO-REN HSUEH2021-05-262021-05-2620091058-4838https://scholars.lib.ntu.edu.tw/handle/123456789/562476[SDGs]SDG3isoniazid; quinolone derivative; rifampicin; bacterium isolate; drug sensitivity; extensively drug resistant tuberculosis; human; letter; multidrug resistant tuberculosis; Mycobacterium tuberculosis; prevalence; priority journal; tuberculosisletter10.1086/5989922-s2.0-66949146185